Title |
Pharmacological and Non-pharmacological Treatment for Decompensated Heart Failure: What Is New?
|
---|---|
Published in |
Current Heart Failure Reports, April 2017
|
DOI | 10.1007/s11897-017-0328-x |
Pubmed ID | |
Authors |
Parin Shah, Pierpaolo Pellicori, Joseph Cuthbert, Andrew L. Clark |
Abstract |
Acute heart failure (AHF) is a life-threatening clinical condition that requires prompt medical attention. The aim of the current review is to summarise the results of recent clinical trials conducted in patients with AHF. Several novel compounds have apparently beneficial acute effects on cardiovascular haemodynamics and patients' symptoms, but their administration has not yet translated into improved survival and has been deleterious in some cases. The management of patients with AHF is challenging and reflects the heterogeneity of patient's presentation, the complexity and severity of a multi-organ syndrome, and the limited therapeutic options, usually restricted to a combination of diuretics and vasodilators. Ongoing trials of novel treatments may provide evidence of an effect on outcomes. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 69 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 15 | 22% |
Student > Master | 7 | 10% |
Other | 6 | 9% |
Lecturer | 4 | 6% |
Researcher | 4 | 6% |
Other | 13 | 19% |
Unknown | 20 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 22 | 32% |
Nursing and Health Professions | 8 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 7% |
Biochemistry, Genetics and Molecular Biology | 2 | 3% |
Unspecified | 2 | 3% |
Other | 6 | 9% |
Unknown | 24 | 35% |